BIO
Michelle McDonald-Alexis, Ph.D.
Vice President, Technical – Regulatory Strategy
Michelle has more than 25 years of drug development experience, which includes post-doctoral research in academia, 10 years at the UK MHRA and non-clinical regulatory support in the Pharma industry. At the MHRA, she was responsible for assessment of non-clinical components of marketing applications and clinical trial applications, and provision of National and European Scientific Advice. At Parexel she provides strategic and technical advice to clients, across a wide range of therapeutic areas and medicinal products.
Education
Michelle has graduated (BSc) in Pharmacology from holds University of Bath in the United Kingdom, and a PhD in Pharmacology from The William Harvey Research Institute at Queen Mary, University of London.